MONTHLY MEETING: Wednesday, March 18th at CKE Community Centre. Dr. Christine Hentschel talks about Meals on Wheels.
A Prostate Cancer Support Group
Dr. Geoffrey Gotto, Urologic Oncologist at the Southern Alberta Institute of Urology, joins us again to explain PARP inhibitors and their importance in modern treatment of cancer cells.
Includes: Spotlighting the Top 10 FDA Oncology Approvals in 2025, CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction,
Includes: Prostate cancer cells thrive in bone tissue, Top 10 Urology Times prostate cancer articles of 2025, Reversing treatment resistance in prostate cancer,
Includes: Focused ultrasound offers safe and effective prostate cancer treatment, Neuromodulation therapy for erectile dysfunction after radical prostatectomy,
Dr. Fedir Razumenko from the University of Calgary joins us for a look at the progression of cancer treatment in Canada, comparing stats from the 1920s to today and how today’s treatments were forged by brave and competitive voices throughout the country.
Includes: Drug combo cuts risk of death in advanced prostate cancer by 40%, targeting enzymes to weaken cancer cells could supercharge treatment,
Dr. Tarek Bismar from the Prostate Cancer Centre joins us again to talk about PARP inhibitors and their role in cancer treatment. He shows their activity in cancer cells, synergy with other cancer therapies, and how people respond depending on their cancer type.
Includes: Tailgating With Dr. Digital 2025, Prostate Cancer Stage Increasing, Survival Gains Slowing in the United States, protecting against erectile dysfunction,
Clinical psychologist Dr. Linda E. Carlson joins us to discuss how to train your mind to deal with the stress that comes with a cancer diagnosis along with providing breathing exercises to help regulate your body systems and cope with everyday stressors.
Includes: Mindfulness for Managing Cancer-Related Stress, Cancer drug eliminates aggressive cancers in Phase I trial, Novel alpha particle therapy holds promise,